Given the critical role of immunomodulatory molecules in cancer immunotherapy, the association between these molecules and PAQR5 expression was examined to construct a comprehensive immune landscape related to PAQR5 (Fig. 3F, S2A). This evidence concerns the gene PAQR5 and cancer.